Revisión-Cáncer de riñón
Ultrasonidos extracorpóreos de alta intensidad: alternativa terapéutica del tumor renal
Extracorporeal high-intensity focused ultrasound: Therapeutic alternative for renal tumors
Leído
4116
Vecesse ha leído el artículo
851
Total PDF
3265
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 11 | 0 | 2 | 2 |
| 2025 10 | 0 | 12 | 12 |
| 2025 9 | 0 | 5 | 5 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 3 | 3 |
| 2025 6 | 0 | 4 | 4 |
| 2025 5 | 0 | 3 | 3 |
| 2025 3 | 0 | 3 | 3 |
| 2025 2 | 0 | 4 | 4 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 2 | 2 |
| 2024 11 | 0 | 1 | 1 |
| 2024 10 | 0 | 2 | 2 |
| 2024 9 | 0 | 5 | 5 |
| 2024 8 | 0 | 3 | 3 |
| 2024 7 | 0 | 3 | 3 |
| 2024 6 | 0 | 7 | 7 |
| 2024 4 | 0 | 2 | 2 |
| 2024 3 | 0 | 6 | 6 |
| 2024 2 | 0 | 12 | 12 |
| 2024 1 | 0 | 3 | 3 |
| 2023 12 | 0 | 18 | 18 |
| 2023 11 | 0 | 8 | 8 |
| 2023 10 | 0 | 3 | 3 |
| 2023 9 | 0 | 4 | 4 |
| 2023 8 | 0 | 2 | 2 |
| 2023 7 | 2 | 15 | 17 |
| 2023 6 | 0 | 1 | 1 |
| 2023 5 | 0 | 4 | 4 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 2 | 0 | 2 |
| 2023 2 | 0 | 3 | 3 |
| 2022 1 | 0 | 3 | 3 |
| 2022 12 | 0 | 3 | 3 |
| 2022 11 | 0 | 6 | 6 |
| 2022 10 | 0 | 4 | 4 |
| 2022 9 | 0 | 3 | 3 |
| 2022 8 | 0 | 4 | 4 |
| 2022 7 | 0 | 1 | 1 |
| 2022 6 | 0 | 4 | 4 |
| 2022 5 | 0 | 6 | 6 |
| 2022 4 | 0 | 5 | 5 |
| 2022 3 | 0 | 3 | 3 |
| 2021 1 | 0 | 4 | 4 |
| 2021 12 | 0 | 2 | 2 |
| 2021 11 | 0 | 4 | 4 |
| 2021 10 | 0 | 5 | 5 |
| 2021 9 | 0 | 5 | 5 |
| 2021 8 | 0 | 4 | 4 |
| 2021 7 | 0 | 7 | 7 |
| 2021 6 | 0 | 6 | 6 |
| 2021 5 | 0 | 4 | 4 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 0 | 7 | 7 |
| 2021 2 | 0 | 12 | 12 |
| 2020 1 | 0 | 4 | 4 |
| 2020 12 | 0 | 1 | 1 |
| 2020 11 | 0 | 8 | 8 |
| 2020 10 | 0 | 2 | 2 |
| 2020 8 | 0 | 2 | 2 |
| 2020 7 | 0 | 2 | 2 |
| 2020 5 | 0 | 1 | 1 |
| 2020 4 | 0 | 1 | 1 |
| 2020 3 | 0 | 2 | 2 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 3 | 3 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 0 | 2 | 2 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 0 | 11 | 11 |
| 2019 5 | 1 | 13 | 14 |
| 2019 4 | 0 | 5 | 5 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 4 | 4 |
| 2019 1 | 0 | 4 | 4 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 0 | 6 | 6 |
| 2018 10 | 0 | 2 | 2 |
| 2018 9 | 0 | 1 | 1 |
| 2018 8 | 0 | 1 | 1 |
| 2018 5 | 1 | 1 | 2 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 13 | 1 | 14 |
| 2018 1 | 4 | 0 | 4 |
| 2017 12 | 8 | 1 | 9 |
| 2017 11 | 10 | 2 | 12 |
| 2017 10 | 14 | 3 | 17 |
| 2017 9 | 12 | 7 | 19 |
| 2017 8 | 11 | 8 | 19 |
| 2017 7 | 11 | 10 | 21 |
| 2017 6 | 22 | 8 | 30 |
| 2017 5 | 23 | 3 | 26 |
| 2017 4 | 26 | 20 | 46 |
| 2017 3 | 33 | 30 | 63 |
| 2017 2 | 32 | 4 | 36 |
| 2016 1 | 30 | 1 | 31 |
| 2016 12 | 46 | 7 | 53 |
| 2016 11 | 61 | 9 | 70 |
| 2016 10 | 42 | 11 | 53 |
| 2016 9 | 102 | 2 | 104 |
| 2016 8 | 47 | 2 | 49 |
| 2016 7 | 28 | 1 | 29 |
| 2016 6 | 32 | 29 | 61 |
| 2016 5 | 47 | 23 | 70 |
| 2016 4 | 26 | 14 | 40 |
| 2016 3 | 42 | 23 | 65 |
| 2016 2 | 38 | 19 | 57 |
| 2015 1 | 26 | 23 | 49 |
| 2015 12 | 39 | 24 | 63 |
| 2015 11 | 35 | 18 | 53 |
| 2015 10 | 41 | 15 | 56 |
| 2015 9 | 19 | 6 | 25 |
| 2015 8 | 58 | 12 | 70 |
| 2015 7 | 92 | 11 | 103 |
| 2015 6 | 31 | 3 | 34 |
| 2015 5 | 48 | 11 | 59 |
| 2015 4 | 36 | 15 | 51 |
| 2015 3 | 96 | 17 | 113 |
| 2015 2 | 124 | 9 | 133 |
| 2015 1 | 63 | 4 | 67 |
| 2014 12 | 67 | 15 | 82 |
| 2014 11 | 59 | 6 | 65 |
| 2014 10 | 87 | 8 | 95 |
| 2014 9 | 72 | 6 | 78 |
| 2014 8 | 50 | 4 | 54 |
| 2014 7 | 66 | 7 | 73 |
| 2014 6 | 69 | 7 | 76 |
| 2014 5 | 48 | 4 | 52 |
| 2014 4 | 40 | 5 | 45 |
| 2014 3 | 47 | 5 | 52 |
| 2014 2 | 66 | 5 | 71 |
| 2014 1 | 44 | 4 | 48 |
| 2013 12 | 42 | 3 | 45 |
| 2013 11 | 32 | 4 | 36 |
| 2013 10 | 47 | 5 | 52 |
| 2013 9 | 36 | 5 | 41 |
| 2013 8 | 34 | 6 | 40 |
| 2013 7 | 9 | 2 | 11 |
| 2010 4 | 875 | 0 | 875 |
Mostrar todo
